Repros Therapeutics Inc. Announces Pricing Of Public Offering Of Common Stock
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) announced today the pricing of its public offering of 2,610,000 shares of its common stock at a public offering price of $13.75 per share. All of the shares are being offered by Repros. The underwriters have a 30-day option to purchase up to an additional 390,000 shares of common stock to cover over-allotments, if any.